Tyro3 Modulates Mertk-Associated Retinal Degeneration

Douglas Vollrath1, Douglas Yasumura2, Gillie Benchorin1

  • 1Department of Genetics, Stanford University School of Medicine, Stanford, California, United States of America.

Plos Genetics
|December 15, 2015
PubMed

Insights

Genetic modifiers influence inherited photoreceptor degeneration. The Tyro3 gene

Area of Science:

  • Genetics
  • Ophthalmology
  • Molecular Biology

Background:

  • Inherited photoreceptor degenerations (IPDs) are highly diverse Mendelian diseases with often unknown causes of phenotypic variability.
  • Mutations in MERTK cause recessive IPDs (RP38), but modifier genes can alter disease progression.

Purpose of the Study:

  • To identify genetic modifiers of MERTK-associated photoreceptor degeneration.
  • To investigate the role of Tyro3 in modulating retinal degeneration and photoreceptor outer segment phagocytosis.

Main Methods:

  • Genetic mapping in a mouse model to identify modifier loci.
  • Quantitative trait locus analysis and gene expression studies (eQTL).
  • In vitro assays using primary retinal pigment epithelium (RPE) cells to assess Tyro3 function in phagocytosis.

Main Results:

  • A genetic modifier locus on chromosome 7 was identified, containing the Tyro3 gene.
  • The C57BL/6 (B6) allele of Tyro3 acts as a suppressor, increasing Tyro3 expression and slowing photoreceptor degeneration in Mertk-deficient mice.
  • Tyro3 protein is involved in the phagocytosis of photoreceptor outer segments by RPE cells.

Conclusions:

  • Tyro3 gene dosage significantly modulates the severity of MERTK-associated retinal degeneration.
  • Tyro3 plays a direct role in RPE phagocytosis, crucial for photoreceptor health.
  • Expression quantitative trait loci (eQTLs) can modify recessive inherited photoreceptor degenerations.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

2.8K